Microbiology Spectrum · 2022 · 17 citations · 38 references
PharmacyPharmacokineticsPharmacologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyAntimicrobial ResistanceAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceCombination Antimicrobial TherapyBroth MicrodilutionCarbapenem-nonsusceptible IsolatesCombination Drug TherapyDrug Combination TherapyDrug-resistant PathogensMinocycline TherapyOnce-daily Dosing RegimensSynergistic Drug Combinations
Treatment of infections due to Acinetobacter baumannii often involves the use of multiple antibiotics simultaneously as combination therapy, but it is unknown which antibiotics are best used together. Tetracycline agents such as minocycline and tigecycline maintain good activity against A. baumannii and are often used with one or more other agents to achieve better killing of the bacteria. Omadacycline is a new tetracycline that may have a role in the treatment of A. baumannii, but no data are available evaluating its interaction with other commonly used drugs such as polymyxin B and sulbactam. Therefore, the purpose of this study was to investigate the antibacterial activity of omadacycline when combined with one or more other agents against carbapenem-resistant strains of A. baumannii. These findings may then be used to design confirmatory studies that could help decide what drugs work best together and what combination of agents should be used for patients.
38
Performance standards for antimicrobial susceptibility testing
Mary Jane Ferraro · 2001 · 9.8K citations
Identification of acquired antimicrobial resistance genes
Ea Zankari, Henrik Hasman, Salvatore Cosentino et al. · Journal of Antimicrobial Chemotherapy · 2012 · 5.2K citations · Full text
Matteo Bassetti, Roger Echols, Yuko Matsunaga et al. · The Lancet Infectious Diseases · 2020 · 792 citations